Trial NCT04383574
Publication Wu Z, Lancet Infect Dis, 2021
Primary outcome on the report: Vaccine-related adverse event (adverse reaction) within 28 days after the administration of each dose of vaccine or placebo; Seroconversion rate of neutralising antibodies to live SARS-CoV-2 at day 28 after the second dose

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.